XTX Topco’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-67,361
Closed -$608K 4445
2025
Q4
$608K Sell
67,361
-135,021
-67% -$1.01M 0.02% 1428
2025
Q3
$629K Buy
202,382
+40,771
+25% +$108K 0.03% 900
2025
Q2
$346K Buy
161,611
+112,660
+230% +$182K 0.01% 1334
2025
Q1
$56.3K Sell
48,951
-50,472
-51% -$86.7K ﹤0.01% 1981
2024
Q4
$218K Sell
99,423
-13,290
-12% -$30.1K 0.02% 1485
2024
Q3
$246K Buy
+112,713
New +$259K 0.02% 1318
2024
Q2
Sell
-37,547
Closed -$207K 2520
2024
Q1
$207K Sell
37,547
-218,998
-85% -$1M 0.03% 1145
2023
Q4
$634K Buy
+256,545
New +$2.44M 0.14% 149

Other funds holding VTYX

XTX Topco's VTYX Position: Q1 2026 in Review

XTX Topco sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 67,361 shares — an estimated $608K sold.

XTX Topco first reported a position in VTYX in Q4 2023 and held it in 8 quarters. The position peaked at $634K in Q4 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • XTX Topco reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 67,361 Ventyx Biosciences shares in Q1 2026, an estimated $608K.
  • XTX Topco first reported a position in Ventyx Biosciences in Q4 2023 and held it in 8 quarters.
  • XTX Topco's Ventyx Biosciences position peaked at $634K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.